Evidence map›Paper›PMID 41596444›Full record

ArticleInternational journal of molecular sciences2026

m6A-Modified Nucleotide Bases Improve Translation of In Vitro-Transcribed Chimeric Antigen Receptor (CAR) mRNA in T Cells.

Nga Lao, Simeng Li, Marina Ainciburu, Niall Barron

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nga LaoNational Institute for Bioprocessing Research and Training, Blackrock, A94 X099 Dublin, Ireland.ORCID 0000-0002-7997-1568
Simeng LiNational Institute for Bioprocessing Research and Training, Blackrock, A94 X099 Dublin, Ireland.ORCID 0000-0002-3358-7544
Marina AinciburuNational Institute for Bioprocessing Research and Training, Blackrock, A94 X099 Dublin, Ireland.
Niall BarronNational Institute for Bioprocessing Research and Training, Blackrock, A94 X099 Dublin, Ireland.

Funding

ENTERPRISE IRELAND DT20200224
6 · The paper itself

Abstract

Lentiviral transduction remains the gold standard in adoptive modified cellular therapy, such as CAR-T; however, genome integration is not always desirable, such as when treating non-fatal autoimmune disease or for additional editing steps using CRISPR to produce allogeneic CAR-modified cells. Delivering in vitro-transcribed (IVT) mRNA represents an alternative solution but the labile nature of mRNA has led to efforts to improve half-life and translation efficiencies using a range of approaches including chemical and structural modifications. In this study, we explore the role of N

Indexed as

AdenosineProtein BiosynthesisReceptors, Chimeric AntigenRNA, MessengerT-LymphocytesEpitranscriptomeHumansRNA MethylationAdenosineN-methyladenosineReceptors, Chimeric AntigenRNA, Messengercell therapyin vitro transcriptionm6ARNA therapyT cell engineeringtransient CAR-TUTR engineering

Identifiers

PMID41596444
PMCPMC12841529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.